May 21, 2010 15:00 ET

SOHM India Signs Sales and Marketing Agreement to Sell Branded Generic Pharmaceutical Products in Africa

SOHM Begins African Sales Expansion Into Uganda, Tanzania and Zambia

BUENA PARK, CA--(Marketwire - May 21, 2010) -  SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced today it has signed a sales and marketing agreement to sell its branded generic pharmaceutical products in Africa. Sales will begin in Uganda, Tanzania, and Zambia under the SOHM brand as soon as the necessary measures have been completed in each country. All of the generic drugs will be produced by SOHM's India-based licensed manufacturing facility.

"Our team has worked diligently to finalize the SOHM brands entry to the African market," stated Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc. "We made a strong commitment to globalize our branded generic pharmaceutical product line and we are well on our way with our new partner in Africa. We have rapidly expanded our market share in India and feel confident we will be very successful in Africa as well. Africa's challenges, like high cases of disease and booming populations, are solid market opportunities and also serve populations in dire need of affordable medications. We will continue to explore other collaborations within Africa that will drive sales of our products across the continent." 

About SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters are located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia.

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    SOHM, Inc.
    Investor Relations
    (714) 522-6700
    Email Contact